Verition Fund Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.05M | Buy |
|
|||||
|
2025
Q1 | $1.99M | Buy |
|
|||||
|
2024
Q4 | $1.46M | Buy |
|
|||||
|
2024
Q3 | $959K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $580K | Buy |
|
|||||
|
2023
Q4 | $250K | Sell |
|
|||||
|
2023
Q3 | $4.58M | Sell |
|
|||||
|
2023
Q2 | $4.19M | Sell |
|
|||||
|
2023
Q1 | $7.04M | Buy |
|
|||||
|
2022
Q4 | $569K | Buy |
|
|||||
|
2022
Q3 | $302K | Sell |
|
|||||
|
2022
Q2 | $369K | Sell |
|
|||||
|
2022
Q1 | $9.71M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $4.16M | Buy |
|
|||||
|
2021
Q1 | $624K | Sell |
|
|||||
|
2020
Q4 | $10M | Buy |
|
|||||
|
2020
Q3 | $495K | Buy |
|
|||||
|
2020
Q2 | $317K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $1.64M | Buy |
|
|||||
|
2019
Q3 | $272K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $339K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $3.54M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $360K | Sell |
|
|||||
|
2017
Q4 | $649K | Buy |
|